These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 3961284)

  • 21. Effects of steroid therapy on pulmonary involvement in sarcoidosis.
    Scano G; Monechi GC; Gigliotti F; Stendardi L; Esposito-Iacenna V; Tarducci G; Schiffini P
    Int J Clin Pharmacol Ther Toxicol; 1983 Sep; 21(9):468-75. PubMed ID: 6629552
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Respiratory function in recent pulmonary sarcoidosis with special reference to small airways.
    Lamberto C; Saumon G; Loiseau P; Battesti JP; Georges R
    Bull Eur Physiopathol Respir; 1985; 21(4):309-15. PubMed ID: 4041656
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lung function abnormalities in cystic fibrosis and changes during growth.
    Zapletal A; Houstek J; Samanek M; Vavrova V; Srajer J
    Bull Eur Physiopathol Respir; 1979; 15(4):575-92. PubMed ID: 497487
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Single breath nitrogen washout in pulmonary sarcoidosis.
    Crawford O; Al-Bazzaz FJ
    Respiration; 1982; 43(3):158-63. PubMed ID: 7111863
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alternate day steroid therapy in diffuse pulmonary sarcoidosis.
    Block AJ; Light RW
    Chest; 1973 Apr; 63(4):495-504. PubMed ID: 4695345
    [No Abstract]   [Full Text] [Related]  

  • 26. Sarcoidosis: a correlation of dyspnea with roentgenographic stage and pulmonary function changes.
    DeRemee RA; Andersen HA
    Mayo Clin Proc; 1974 Oct; 49(10):742-5. PubMed ID: 4422825
    [No Abstract]   [Full Text] [Related]  

  • 27. Small airways function in pulmonary sarcoidosis.
    Radwan L; Grebska E; Koziorowski A
    Scand J Respir Dis; 1978 Feb; 59(1):37-43. PubMed ID: 653325
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lung function declines in patients with pulmonary sarcoidosis and increased respiratory epithelial permeability to 99mTc-DTPA.
    Chinet T; Dusser D; Labrune S; Collignon MA; Chrétien J; Huchon GJ
    Am Rev Respir Dis; 1990 Feb; 141(2):445-9. PubMed ID: 2405760
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Increased closing volume in asymptomatic respiratory sarcoidosis].
    Favez G; Raaflaub B
    Schweiz Med Wochenschr; 1977 Mar; 107(12):402-5. PubMed ID: 847443
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Small airway disease: comparison of tests in young smokers versus nonsmokers.
    Harrison GN; Moor GR; Mohler JL; Speir WA
    South Med J; 1978 Sep; 71(9):1079-81. PubMed ID: 684495
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pulmonary disease progress in sarcoid patients with and without bronchoalveolar lavage collagenase.
    Ward K; O'Connor CM; Odlum C; Power C; Fitzgerald MX
    Am Rev Respir Dis; 1990 Sep; 142(3):636-41. PubMed ID: 2167622
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Underestimation of bronchial obstruction in sarcoidosis].
    Le Merre C; Rousset G; Prefaut C
    Respiration; 1986; 50(2):88-96. PubMed ID: 3749617
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of corticosteroid treatment on pulmonary haemodynamics in patients with sarcoidosis.
    Gluskowski J; Hawrylkiewicz I; Zych D; Zieliński J
    Eur Respir J; 1990 Apr; 3(4):403-7. PubMed ID: 2365034
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prediction of therapeutic response in steroid-treated pulmonary sarcoidosis.
    Snider GL
    Am Rev Respir Dis; 1985 Nov; 132(5):1139-40. PubMed ID: 4062046
    [No Abstract]   [Full Text] [Related]  

  • 35. Lung function in pulmonary sarcoidosis.
    Kowalski J; Grebska E; Krychniak W
    Z Erkr Atmungsorgane; 1977 Aug; 149(2):271-3. PubMed ID: 610103
    [No Abstract]   [Full Text] [Related]  

  • 36. Effects of oral steroids on immunoglobulins in bronchoalveolar lavage fluid in active sarcoidosis.
    Spatafora M; Mirabella A; Rossi GA; Bonanno A; Riccobono L; Merendino A; Bellia V; Bonsignore G
    Eur Respir J; 1988 Jun; 1(6):505-9. PubMed ID: 3262533
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical Utility of Additional Measurement of Total Lung Capacity in Diagnosing Obstructive Lung Disease in Subjects With Restrictive Pattern of Spirometry.
    Lee H; Chang B; Kim K; Song WJ; Chon HR; Kang HK; Kim JS; Jeong BH; Oh YM; Koh WJ; Park HY
    Respir Care; 2016 Apr; 61(4):475-82. PubMed ID: 26884447
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum procollagen III peptide levels in subjects with sarcoidosis. A 5-year follow-up study.
    Pohl WR; Thompson AB; Köhn H; Losch S; Umek H; Legenstein E; Kummer F; Rennard SI; Klech H
    Am Rev Respir Dis; 1992 Feb; 145(2 Pt 1):412-7. PubMed ID: 1310576
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence that steroids alter the natural history of previously untreated progressive pulmonary sarcoidosis.
    Odlum CM; FitzGerald MX
    Sarcoidosis; 1986 Mar; 3(1):40-6. PubMed ID: 3575916
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Long term data of functional respiratory exploration in subjects cured of pulmonary sarcoidosis].
    Turiaf J; Basset G; Georges R
    Poumon Coeur; 1969; 25(1):1-15. PubMed ID: 5403114
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.